TABLE 1.
Patient characteristics.
| Characteristics | No. of patients (%) |
|---|---|
| Mean age (years) | 62.97 ± 10.9 |
| Gender | |
| Male | 87 (62.6%) |
| Female | 52 (37.4%) |
| Cancer-related family history | |
| Yes | 4 (2.9%) |
| No | 135 (97.1%) |
| Smoking status | |
| Non-smoker | 115 (82.7%) |
| Ever smoker | 24 (17.3%) |
| Dosage | |
| 8 mg | 73 (52.5%) |
| 12 mg | 66 (47.5%) |
| ECOG score | |
| 0 | 38 (27.3%) |
| 1 | 85 (61.2%) |
| ≥2 | 16 (11.5%) |
| Histology | |
| Adenocarcinoma | 77 (55.4%) |
| Squamous cell carcinoma | 27 (19.4%) |
| Small cell | 21 (15.1%) |
| Others | 14 (10.1%) |
| Clinical stage n (%) | |
| IIIB | 19 (13.7%) |
| IV | 120 (86.3%) |
| Treatment line | |
| <3rd line | 47 (33.8%) |
| ≥3rd line | 92 (66.2%) |
| EGFR mutation | |
| Yes | 17 (12.2%) |
| No | 87 (62.6%) |
| Unknown | 35 (25.2%) |
| Prior targeted therapy | |
| Yes | 41 (29.5%) |
| No | 98 (70.5%) |
| Prior thoracic radiotherapy | |
| Yes | 39 (28.1%) |
| No | 100 (71.9%) |
| Prior anti-angiogenesis treatment | |
| Yes | 44 (31.7%) |
| No | 95 (68.3%) |
| Surgical history | |
| Yes | 101 (72.7%) |
| No | 38 (27.3%) |